A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03

Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601

10.1111/bjh.13818 ◽

2015 ◽

Vol 172 (2) ◽

pp. 208-218 ◽

Cited By ~ 26

Author(s):

Brian G. Till ◽

Hongli Li ◽

Steven H. Bernstein ◽

Richard I. Fisher ◽

W. Richard Burack ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Induction Therapy ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

Newly Diagnosed ◽

COMBINATION OF IBRUTINIB WITH RITUXIMAB (IR) IS HIGHLY EFFECTIVE IN PREVIOUSLY UNTREATED ELDERLY (>65 YEARS) PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) - PHASE II TRIAL

Hematological Oncology ◽

10.1002/hon.11_2629 ◽

2019 ◽

Vol 37 ◽

pp. 42-42

Author(s):

P. Jain ◽

J. Romaguera ◽

K. Nomie ◽

S. Zhang ◽

L. Wang ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

Mantle Cell ◽

Highly Effective

Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

Annals of Oncology ◽

10.1093/annonc/mdr450 ◽

2012 ◽

Vol 23 (6) ◽

pp. 1555-1561 ◽

Cited By ~ 32

Author(s):

R. Houot ◽

S. Le Gouill ◽

M. Ojeda Uribe ◽

C. Mounier ◽

S. Courby ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.tps223 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. TPS223-TPS223 ◽

Cited By ~ 1

Author(s):

V. A. Morrison ◽

S. Jung ◽

J. L. Johnson ◽

J. Leonard ◽

B. D. Cheson ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma

10.1111/bjh.16714 ◽

2020 ◽

Author(s):

Fulvio Massaro ◽

Yana Stepanishyna ◽

Martina Manni ◽

Stefano Luminari ◽

Sara Galimberti ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Initial Treatment ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

Long Term Results ◽

High Dose ◽

Mantle Cell ◽

High Dose Cytarabine

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial

Leukemia ◽

10.1038/leu.2015.215 ◽

2015 ◽

Vol 30 (4) ◽

pp. 984-987 ◽

Cited By ~ 4

Author(s):

S Ferrero ◽

◽

A Pastore ◽

C W Scholz ◽

R Forstpointner ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma - a phase II trial

10.1111/bjh.12769 ◽

2014 ◽

Vol 165 (4) ◽

pp. 575-578 ◽

Cited By ~ 26

Author(s):

Michelle Furtado ◽

Martin J. S. Dyer ◽

Rod Johnson ◽

Margie Berrow ◽

Simon Rule

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma

10.1111/j.1365-2141.2008.07271.x ◽

2008 ◽

Vol 143 (2) ◽

pp. 201-209 ◽

Cited By ~ 13

Author(s):

Owen A. O’Connor ◽

Carol Portlock ◽

Craig Moskowitz ◽

David Straus ◽

Paul Hamlin ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Hodgkin Lymphoma ◽

Clinical Experience ◽

Phase Ii ◽

Cell Lymphoma ◽

The Novel ◽

Multicentre Phase ◽

Non Hodgkin Lymphoma ◽

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2018.05.023 ◽

2018 ◽

Vol 18 (9) ◽

pp. 569-575.e1 ◽

Cited By ~ 15

Author(s):

Victor Yazbeck ◽

Danielle Shafer ◽

Edward B. Perkins ◽

Domenico Coppola ◽

Lubomir Sokol ◽

...

Keyword(s):

B Cell ◽

Mantle Cell Lymphoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Mantle Cell ◽

Large B Cell

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group

Haematologica ◽

10.3324/haematol.2009.011759 ◽

2010 ◽

Vol 95 (8) ◽

pp. 1350-1357 ◽

Cited By ~ 27

Author(s):

R. Gressin ◽

S. Caulet-Maugendre ◽

E. Deconinck ◽

O. Tournilhac ◽

E. Gyan ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Phase Ii ◽

Cell Lymphoma ◽

Newly Diagnosed ◽

Phase Ii Trials ◽

Mantle Cell ◽

Prospective Phase